Clinical Trial Update: Efficacy and Safety of Lanthanum Carbonate in Reducing Serum Phosphorus Levels in Subjects With Stage 3 and 4 Chronic Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update on lanthanum carbonate for reducing serum phosphorus in stage 3–4 chronic kidney disease; focuses on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• LANTHANUM CARBONATE (lanthanum carbonate)

Snippet

Sponsor: Shire | Conditions: Kidney Diseases | Phase 2 | Status: COMPLETED